Our Pricing

Securing a wegovy prescription uk online has never been more straightforward for eligible patients. At Cured Pharmacy, you'll complete a free clinical assessment with our UK-registered prescribers in under 3 minutes, receive transparent pricing from £79.00, and have your genuine UK-licensed Wegovy delivered discreetly to your door.

How Wegovy Works for Weight Loss

Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural hormone glucagon-like peptide-1 to regulate appetite and food intake [1]. By activating GLP-1 receptors in the brain, Wegovy reduces hunger signals and increases feelings of fullness after eating, helping patients achieve sustained weight reduction when combined with lifestyle modifications.

In the landmark STEP 1 trial involving 1,961 adults with obesity, participants using Wegovy achieved an average body weight reduction of 14.9% over 68 weeks, compared to 2.4% with placebo [1]. These results led to MHRA approval and established Wegovy as one of the most effective pharmacological weight management options available in the UK. Clinical data shows that approximately two-thirds of patients on Wegovy lose at least 10% of their starting body weight when treatment is combined with reduced-calorie diet and increased physical activity [2].

Wegovy Prescription Requirements in the UK

Who Can Be Prescribed Wegovy?

Wegovy is licensed in the UK for adults with a body mass index (BMI) of 30 kg/m² or greater, or 27 kg/m² or greater with at least one weight-related comorbidity such as type 2 diabetes, hypertension, or obstructive sleep apnoea [3]. Our UK prescribers assess your medical history, current medications, and weight loss goals during the online consultation to determine if Wegovy is clinically appropriate for you.

Certain medical conditions may preclude Wegovy use, including personal or family history of medullary thyroid carcinoma, multiple endocrine neoplasia syndrome type 2, severe gastrointestinal disease, or diabetic retinopathy complications [3]. Pregnancy and breastfeeding are also contraindications. Your prescriber will review these factors during your assessment to ensure safe, effective treatment.

Wegovy Dosing Schedule and Administration

Wegovy follows a gradual dose escalation protocol over 16 to 20 weeks to minimise gastrointestinal side effects whilst optimising weight loss outcomes [4]. Treatment begins with 0.25 mg once weekly for four weeks, then increases monthly through 0.5 mg, 1 mg, and 1.7 mg doses before reaching the maintenance dose of 2.4 mg once weekly.

Each Wegovy pen is pre-filled and designed for subcutaneous injection into the abdomen, thigh, or upper arm. Patients rotate injection sites weekly to reduce the risk of lipodystrophy. The once-weekly dosing schedule offers significant convenience compared to daily injectable alternatives, and the pen device requires no dose preparation or measurement. Our pharmacy team provides comprehensive administration guidance with every prescription to ensure you feel confident using your medication correctly.

Wegovy vs Mounjaro: Clinical Comparison

Comparing Mechanisms and Outcomes

Whilst Wegovy activates GLP-1 receptors exclusively, Mounjaro (tirzepatide) functions as a dual GIP/GLP-1 receptor agonist, engaging two complementary metabolic pathways [5]. Head-to-head trial data suggests tirzepatide may produce greater average weight reduction in some patient populations, though individual responses vary considerably based on metabolic factors, adherence, and lifestyle modifications.

Both medications are administered once weekly via subcutaneous injection and share similar side effect profiles, predominantly gastrointestinal symptoms during dose escalation. Your UK prescriber will consider your medical history, treatment preferences, budget, and clinical goals when recommending the most suitable option. Neither medication is inherently superior — the optimal choice depends on individual patient factors and prescriber clinical judgement.

Common Side Effects and Management Strategies

The most frequently reported side effects with Wegovy are gastrointestinal in nature, including nausea, diarrhoea, vomiting, constipation, and abdominal discomfort [1]. These symptoms typically emerge during dose escalation and diminish over time as the body adapts to the medication. In clinical trials, nausea affected approximately 44% of Wegovy users, though most cases were mild to moderate in severity.

To minimise gastrointestinal symptoms, our prescribers recommend eating smaller, more frequent meals, avoiding high-fat foods, staying well-hydrated, and taking the injection on the same day each week. If side effects become troublesome, your prescriber may slow the dose escalation schedule or temporarily maintain a lower dose. Serious adverse events are rare but include pancreatitis, gallbladder disease, and hypoglycaemia in patients taking concurrent diabetes medications [3]. Contact your prescriber immediately if you experience severe abdominal pain, persistent vomiting, or signs of allergic reaction.

Getting Your Wegovy Prescription UK Online at Cured Pharmacy

Our Streamlined Prescription Process

Start by completing our free online clinical questionnaire, which takes under 3 minutes and covers your medical history, current medications, weight loss goals, and any contraindications. A UK-registered prescriber from our clinical team, overseen by Superintendent Pharmacist Tarun Kumar (GPhC 2233073), reviews your assessment within hours. If Wegovy is deemed clinically appropriate and safe for you, your prescription is issued and sent directly to our GPhC-registered pharmacy (9012511) for dispensing.

We provide transparent upfront pricing from £79.00 — you'll see the exact cost before completing your consultation, with no hidden fees or surprise charges. Your Wegovy is dispensed as genuine UK-licensed medication and delivered in 100% discreet packaging. We offer the lowest prices guaranteed in the UK whilst maintaining the highest standards of pharmaceutical care and regulatory compliance.

Scientific References

1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
2. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA, 325(14), 1414–1425. https://doi.org/10.1001/jama.2021.3224
3. Novo Nordisk. (2023). Wegovy 2.4 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/13799
4. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971–984. https://doi.org/10.1016/S0140-6736(21)00213-0
5. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.